DE3001842A1 - Verfahren zum reinigen von liposomensuspensionen - Google Patents
Verfahren zum reinigen von liposomensuspensionenInfo
- Publication number
- DE3001842A1 DE3001842A1 DE19803001842 DE3001842A DE3001842A1 DE 3001842 A1 DE3001842 A1 DE 3001842A1 DE 19803001842 DE19803001842 DE 19803001842 DE 3001842 A DE3001842 A DE 3001842A DE 3001842 A1 DE3001842 A1 DE 3001842A1
- Authority
- DE
- Germany
- Prior art keywords
- resins
- liposomes
- liposome suspensions
- groups
- suspensions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002502 liposome Substances 0.000 title claims description 44
- 239000000725 suspension Substances 0.000 title claims description 31
- 238000000034 method Methods 0.000 title claims description 23
- 238000004140 cleaning Methods 0.000 title claims description 5
- 239000011347 resin Substances 0.000 claims description 23
- 229920005989 resin Polymers 0.000 claims description 23
- 229920003303 ion-exchange polymer Polymers 0.000 claims description 6
- 150000002632 lipids Chemical group 0.000 claims description 6
- 239000003456 ion exchange resin Substances 0.000 claims description 5
- 229940126601 medicinal product Drugs 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 4
- 239000003463 adsorbent Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- MWWSFMDVAYGXBV-RUELKSSGSA-N Doxorubicin hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-RUELKSSGSA-N 0.000 claims description 3
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims description 3
- 229960002949 fluorouracil Drugs 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- LJRDOKAZOAKLDU-UDXJMMFXSA-N (2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(2r,3s,4r,5s)-5-[(1r,2r,3s,5r,6s)-3,5-diamino-2-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 claims description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- 229960002918 doxorubicin hydrochloride Drugs 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 239000011261 inert gas Substances 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 230000000087 stabilizing effect Effects 0.000 claims description 2
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 claims 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims 2
- 238000009833 condensation Methods 0.000 claims 2
- 230000005494 condensation Effects 0.000 claims 2
- 238000000605 extraction Methods 0.000 claims 2
- 229930195733 hydrocarbon Natural products 0.000 claims 2
- 150000002430 hydrocarbons Chemical class 0.000 claims 2
- 150000002734 metacrylic acid derivatives Chemical class 0.000 claims 2
- 229920001568 phenolic resin Polymers 0.000 claims 2
- 150000003839 salts Chemical group 0.000 claims 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 238000007664 blowing Methods 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 229920000620 organic polymer Polymers 0.000 claims 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-N phosphine group Chemical group P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims 1
- 239000012609 strong anion exchange resin Substances 0.000 claims 1
- 229920001059 synthetic polymer Polymers 0.000 claims 1
- 150000003512 tertiary amines Chemical class 0.000 claims 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims 1
- 239000012610 weak anion exchange resin Substances 0.000 claims 1
- 239000012608 weak cation exchange resin Substances 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 8
- 238000004108 freeze drying Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 229960004679 doxorubicin Drugs 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RNPXCFINMKSQPQ-UHFFFAOYSA-N dicetyl hydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCCCCCC RNPXCFINMKSQPQ-UHFFFAOYSA-N 0.000 description 3
- 229940093541 dicetylphosphate Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000008344 egg yolk phospholipid Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 3
- 238000005199 ultracentrifugation Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000013003 healing agent Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical group [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- ZXHDFKAHCABVAF-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;methyl 2-methylprop-2-enoate Chemical compound COC(=O)C(C)=C.C=CC1=CC=CC=C1C=C ZXHDFKAHCABVAF-UHFFFAOYSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- -1 cholesterol Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229920013730 reactive polymer Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT19434/79A IT1110989B (it) | 1979-01-19 | 1979-01-19 | Forme farmaceutiche costitutite da liposomi e procedimenti relativi |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3001842A1 true DE3001842A1 (de) | 1980-07-31 |
| DE3001842C2 DE3001842C2 (enExample) | 1990-04-26 |
Family
ID=11157905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19803001842 Granted DE3001842A1 (de) | 1979-01-19 | 1980-01-18 | Verfahren zum reinigen von liposomensuspensionen |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS55100313A (enExample) |
| AT (1) | AT370623B (enExample) |
| AU (1) | AU536823B2 (enExample) |
| BE (1) | BE881225A (enExample) |
| CA (1) | CA1148470A (enExample) |
| CH (1) | CH648205A5 (enExample) |
| CS (1) | CS227010B2 (enExample) |
| DE (1) | DE3001842A1 (enExample) |
| DK (1) | DK157060C (enExample) |
| FI (1) | FI70672C (enExample) |
| FR (1) | FR2446635B1 (enExample) |
| GB (1) | GB2041871B (enExample) |
| HU (1) | HU184714B (enExample) |
| IE (1) | IE49141B1 (enExample) |
| IL (1) | IL59120A (enExample) |
| IT (1) | IT1110989B (enExample) |
| NL (1) | NL8000139A (enExample) |
| SE (1) | SE445171B (enExample) |
| SU (1) | SU1367839A3 (enExample) |
| YU (1) | YU44003B (enExample) |
| ZA (1) | ZA80269B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0834309A3 (de) * | 1996-09-27 | 2000-01-19 | Artur Herzog Dr. Mesmer | Verwendung einer Liposomenlösung zur Verstärkung der Wirksamkeit und/oder Verminderung der Toxizität von Arzneimitteln |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU184141B (en) * | 1979-12-27 | 1984-07-30 | Human Oltoanyagtermelo | Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof |
| FR2521565B1 (fr) * | 1982-02-17 | 1985-07-05 | Dior Sa Parfums Christian | Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees |
| FR2553002B1 (fr) * | 1983-10-06 | 1992-03-27 | Centre Nat Rech Scient | Procede perfectionne d'obtention de liposomes unilamellaires de diametres eleves, leur application pharmacologique pour l'encapsulage d'un principe actif en vue de son administration extemporanee et dispositif correspondant |
| CA1270198C (en) * | 1984-08-08 | 1990-06-12 | Marcel B Bally | ENCAPSULATION OF ANTINEOPLASTIC AGENTS IN LIPOSONES |
| US5736155A (en) * | 1984-08-08 | 1998-04-07 | The Liposome Company, Inc. | Encapsulation of antineoplastic agents in liposomes |
| US4755388A (en) * | 1984-11-09 | 1988-07-05 | The Regents Of The University Of California | Liposome-encapsulated 5-fluoropyrimidines and methods for their use |
| IL79114A (en) * | 1985-08-07 | 1990-09-17 | Allergan Pharma | Method and composition for making liposomes |
| US6406713B1 (en) * | 1987-03-05 | 2002-06-18 | The Liposome Company, Inc. | Methods of preparing low-toxicity drug-lipid complexes |
| AU660288B2 (en) * | 1990-07-31 | 1995-06-22 | Transave, Inc. | Accumulation of amino acids and peptides into liposomes |
| DE4107152C2 (de) * | 1991-03-06 | 1994-03-24 | Gregor Cevc | Präparate zur nichtinvasiven Verabreichung von Antidiabetica |
| DE4107153A1 (de) * | 1991-03-06 | 1992-09-10 | Gregor Cevc | Praeparat zur wirkstoffapplikation in kleinsttroepfchenform |
| JPH04127874U (ja) * | 1991-05-13 | 1992-11-20 | 株式会社新潟鐵工所 | コンクリートポンプ用輸送管の圧送音緩和装置 |
| JPH04134673U (ja) * | 1991-06-07 | 1992-12-15 | 株式会社フジタ | コンクリート圧送圧変動防止装置 |
| JPH09502700A (ja) * | 1993-04-02 | 1997-03-18 | ザ リポソーム カンパニー、インコーポレーテッド | リポソームの製造方法 |
| IT1270678B (it) * | 1994-10-20 | 1997-05-07 | Bayer Ag | Liposomi al chetoprofen |
| JP4283355B2 (ja) * | 1997-11-10 | 2009-06-24 | 久光製薬株式会社 | 薬剤用徐放化剤及びそれを含有した徐放性医薬組成物 |
| WO1999024072A1 (fr) * | 1997-11-10 | 1999-05-20 | Hisamitsu Pharmaceutical Co., Inc. | Agent a liberation prolongee pour medicaments et composition pharmaceutique a liberation prolongee |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2842608C2 (de) * | 1977-09-30 | 1986-02-06 | Farmitalia Carlo Erba S.p.A., Mailand/Milano | Verfahren zur Herstellung von injizierbaren Liposomen |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2249552A1 (de) * | 1971-10-12 | 1973-05-30 | Inchema S A | Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen |
| JPS5126213A (ja) * | 1974-08-21 | 1976-03-04 | Tanabe Seiyaku Co | Johoseibiryushiseizaino seiho |
| US4131815A (en) * | 1977-02-23 | 1978-12-26 | Oceanography International Corporation | Solid piezoelectric sand detection probes |
| GB1575343A (en) * | 1977-05-10 | 1980-09-17 | Ici Ltd | Method for preparing liposome compositions containing biologically active compounds |
-
1979
- 1979-01-19 IT IT19434/79A patent/IT1110989B/it active
-
1980
- 1980-01-09 NL NL8000139A patent/NL8000139A/nl not_active Application Discontinuation
- 1980-01-14 JP JP219280A patent/JPS55100313A/ja active Granted
- 1980-01-14 AU AU54581/80A patent/AU536823B2/en not_active Ceased
- 1980-01-14 YU YU81/80A patent/YU44003B/xx unknown
- 1980-01-14 IL IL59120A patent/IL59120A/xx unknown
- 1980-01-15 CA CA000343663A patent/CA1148470A/en not_active Expired
- 1980-01-15 CS CS80309A patent/CS227010B2/cs unknown
- 1980-01-15 AT AT0019380A patent/AT370623B/de not_active IP Right Cessation
- 1980-01-15 FR FR808000801A patent/FR2446635B1/fr not_active Expired
- 1980-01-16 IE IE91/80A patent/IE49141B1/en unknown
- 1980-01-16 ZA ZA00800269A patent/ZA80269B/xx unknown
- 1980-01-17 CH CH370/80A patent/CH648205A5/de not_active IP Right Cessation
- 1980-01-17 FI FI800151A patent/FI70672C/fi not_active IP Right Cessation
- 1980-01-17 HU HU8097A patent/HU184714B/hu not_active IP Right Cessation
- 1980-01-17 SU SU802869298A patent/SU1367839A3/ru active
- 1980-01-17 GB GB8001545A patent/GB2041871B/en not_active Expired
- 1980-01-18 BE BE0/199021A patent/BE881225A/fr not_active IP Right Cessation
- 1980-01-18 SE SE8000443A patent/SE445171B/sv not_active IP Right Cessation
- 1980-01-18 DE DE19803001842 patent/DE3001842A1/de active Granted
- 1980-01-18 DK DK022380A patent/DK157060C/da not_active IP Right Cessation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2842608C2 (de) * | 1977-09-30 | 1986-02-06 | Farmitalia Carlo Erba S.p.A., Mailand/Milano | Verfahren zur Herstellung von injizierbaren Liposomen |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0834309A3 (de) * | 1996-09-27 | 2000-01-19 | Artur Herzog Dr. Mesmer | Verwendung einer Liposomenlösung zur Verstärkung der Wirksamkeit und/oder Verminderung der Toxizität von Arzneimitteln |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5458180A (en) | 1980-07-24 |
| DK22380A (da) | 1980-07-20 |
| IT1110989B (it) | 1986-01-13 |
| ATA19380A (de) | 1982-09-15 |
| DE3001842C2 (enExample) | 1990-04-26 |
| FR2446635A1 (fr) | 1980-08-14 |
| NL8000139A (nl) | 1980-07-22 |
| IL59120A0 (en) | 1980-05-30 |
| FI70672C (fi) | 1986-10-06 |
| JPS55100313A (en) | 1980-07-31 |
| IE800091L (en) | 1980-07-19 |
| HU184714B (en) | 1984-10-29 |
| FR2446635B1 (fr) | 1989-03-10 |
| BE881225A (fr) | 1980-07-18 |
| CS227010B2 (en) | 1984-04-16 |
| AT370623B (de) | 1983-04-25 |
| AU536823B2 (en) | 1984-05-24 |
| ZA80269B (en) | 1981-06-24 |
| GB2041871A (en) | 1980-09-17 |
| CA1148470A (en) | 1983-06-21 |
| YU44003B (en) | 1990-02-28 |
| GB2041871B (en) | 1983-04-13 |
| SE445171B (sv) | 1986-06-09 |
| SU1367839A3 (ru) | 1988-01-15 |
| IT7919434A0 (it) | 1979-01-19 |
| CH648205A5 (de) | 1985-03-15 |
| IL59120A (en) | 1984-05-31 |
| FI800151A7 (fi) | 1980-07-20 |
| DK157060B (da) | 1989-11-06 |
| DK157060C (da) | 1990-04-09 |
| YU8180A (en) | 1983-12-31 |
| JPH0133446B2 (enExample) | 1989-07-13 |
| SE8000443L (sv) | 1980-07-20 |
| IE49141B1 (en) | 1985-08-07 |
| FI70672B (fi) | 1986-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3001842A1 (de) | Verfahren zum reinigen von liposomensuspensionen | |
| US4460577A (en) | Pharmaceutical compositions consisting or consisting essentially of liposomes, and processes for making same | |
| DE3785198T2 (de) | Liposomes praeparat und antibiotikum. | |
| EP0056781B1 (de) | Verfahren zur Herstellung von liposomalen Arzneimitteln | |
| DE3853219T2 (de) | Methode zur Entfernung von Serum-Amyloid-Protein. | |
| DE2747378A1 (de) | Liposomen, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
| DE2845326C2 (de) | Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung | |
| EP0319862B1 (de) | Biocompatible Dialysemembran aus Cellulose mit erhöhter Beta-2-Microglobulinadsorption | |
| DE2532317A1 (de) | Verfahren zur herstellung von liposomen | |
| DE3024858A1 (de) | Anhaltend freigebende pharmazeutische zubereitung eines festen medikamentmaterials | |
| EP0122219A2 (de) | Resinat einer substituierten Carbonsäure, Verfahren zu seiner Herstellung, seine Verwendung und dieses enthaltende pharmazeutische Präparate | |
| DE3335701A1 (de) | Verfahren zur herstellung grosser multilamellarer lipidblaeschen | |
| CH641358A5 (de) | Pharmazeutisches praeparat, enthaltend ein herzglykosid in kombination mit einem polymeren und verfahren zur herstellung desselben. | |
| EP0793095A1 (de) | Durch Festkörper unterstützte Membran-Biosensoren | |
| DE69420712T2 (de) | Verfahren zur extraktion von sphingomyelin | |
| WO2004030649A2 (de) | Methode zur herstellung und stabilisierung von mikro- und nanosuspensionen mit amphiphilen und polyelektrolyten | |
| DE102017113853A1 (de) | Hämokompatibler Adsorber zur Dialyse proteingebundener Urämietoxine | |
| DE2752728C2 (de) | Pharmazeutische Zubereitung mit verzögerter Abgabe | |
| DE69113036T2 (de) | Verzögerte arzneistoffabgabe durch topische anwendung bioadhäsiver liposomen. | |
| DE2223896A1 (de) | Verfahren zum ueberziehen von feinteiligen arzneimitteln | |
| CH642540A5 (de) | Verfahren zum reinigen von liposomensuspensionen. | |
| CH638398A5 (de) | Verfahren zur herstellung von eine pharmazeutische verbindung enthaltenden mikrokapseln. | |
| DE2550011C2 (de) | Verfahren zur Herstellung eines antihämophilen Mittels | |
| DE102019109646A1 (de) | Verfahren und Vorrichtung zur Reinigung von Blut | |
| DE1792230C2 (de) | Trennmedium zur Gelfiltration und Verfahren zu dessen Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8127 | New person/name/address of the applicant |
Owner name: FARMITALIA CARLO ERBA S.R.L., MAILAND/MILANO, IT |
|
| 8128 | New person/name/address of the agent |
Representative=s name: DANNENBERG, G., DIPL.-ING., 6000 FRANKFURT WEINHOL |
|
| 8125 | Change of the main classification |
Ipc: B01J 13/02 |
|
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |